Embrace opportunities under five-year NHS plan, pharmacists urged Pharmacy organisations have identified opportunities to integrate more with other services and have a real impact on improving patient care within the five-year NHS plan.…
Clinical Pharmacist’s monthly news round-up: the top 10 in October 2014What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month……
Public call for Roche to cut price of breast cancer drug An online petition calls on the drug company Roche to lower the price of its breast cancer drug Kadcyla to make it cheap enough to be made available on the NHS.…
New medicine service guaranteed a place in pharmacy, conference hears The new medicine service is here to stay for the foreseeable future, according to the chief executive of the Pharmaceutical Services Negotiating Committee.…
Day Lewis pilots two-pharmacist model in a bid to win services Day Lewis Pharmacy, which has more than 220 pharmacies in the UK, is piloting a two-pharmacist model within its pharmacies in a bid to win services.…
Price cut of 25% proposed for medicines on statutory scheme in England The maximum price pharmaceutical companies can charge the NHS for branded medicines could be reduced by 25% under proposals by the Department of Health.…
Local pharmaceutical committees should consider merging Local pharmaceutical committees (LPCs) should consider merging to improve their chances of winning bids for services from commissioning bodies.…
NICE puts brakes on its planned overhaul of drugs evaluation processes England’s health technology body will not push ahead with its proposed introduction of value-based assessments — including burden of illness and societal impact — in the evaluation of new drugs for use by the NHS.…
Pharmaceutical industry pays £150m back to NHSThe pharmaceutical industry has paid £150m to the NHS in the first six months under the new terms of the Pharmaceutical Price Regulation Scheme (PPRS), which was agreed with the Department of Health in November 2013.…
World’s most expensive drug gets green light from NICE The National Institute for Health and Care Excellence has paved the way for making the most expensive drug in the world available on the NHS.…
